Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extensive Stage Lung Small Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05874401
What this trial is testing

Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Pharmacosmos A/S 302
Not applicableUnknownNCT06323265
What this trial is testing

A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Hebei Medical University Fourth Hospital 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05796089
What this trial is testing

Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy

Who this might be right for
Extensive-Stage Small-Cell Lung Cancer
Trans Tasman Radiation Oncology Group 35
Early research (Phase 1)Ended earlyNCT00807755
What this trial is testing

Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 5
Large-scale testing (Phase 3)Study completedNCT03066778
What this trial is testing

Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Who this might be right for
Small Cell Lung Cancer (SCLC)
Merck Sharp & Dohme LLC 453
Testing effectiveness (Phase 2)Looking for participantsNCT06838208
What this trial is testing

Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC

Who this might be right for
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Anhui Provincial Cancer Hospital 56
Large-scale testing (Phase 3)Study completedNCT00363415
What this trial is testing

Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Eli Lilly and Company 908
Not applicableStudy completedNCT05933863
What this trial is testing

Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance

Who this might be right for
SCLC,Extensive Stage
Peking University Cancer Hospital & Institute 168
Not applicableStudy completedNCT01015963
What this trial is testing

Studying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT04472949
What this trial is testing

Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).

Who this might be right for
Small Cell Lung CancerLung Cancer
Swiss Cancer Institute 46
Testing effectiveness (Phase 2)Looking for participantsNCT07339059
What this trial is testing

Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer ( SCLC )Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Bindu R Potugari 35
Early research (Phase 1)Looking for participantsNCT06348797
What this trial is testing

Phase I Clinical Study of α-PD-L1/DLL3 CAR-T in Patients With R/R SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Sichuan University 30
Not applicableStudy completedNCT00974610
What this trial is testing

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Cancer Trials Ireland 803
Not applicableNot Yet RecruitingNCT07308379
What this trial is testing

Real-World Study of Toripalimab in Extensive-Stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageToripalimab
Fudan University 1,200
Testing effectiveness (Phase 2)UnknownNCT04985201
What this trial is testing

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Who this might be right for
Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Not applicableUnknownNCT05761977
What this trial is testing

Durvalumab in Combination With Standard Chemotherapy of Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Small-cell Lung CancerExtensive-stage Small-cell Lung Cancer
Hellenic Cooperative Oncology Group 50
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Very early researchEnded earlyNCT00253461
What this trial is testing

11C Topotecan PET Imaging

Who this might be right for
Lung CancerMetastatic CancerOvarian Cancer+1 more
Case Comprehensive Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT02580994
What this trial is testing

Pembrolizumab in Untreated Extensive SCLC

Who this might be right for
Small Cell Lung Cancer (SCLC)
European Organisation for Research and Treatment of Cancer - EORTC 125
Testing effectiveness (Phase 2)UnknownNCT06406673
What this trial is testing

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Who this might be right for
Extensive Small Cell Lung Cancer
Henan Cancer Hospital 70
Next Page